article thumbnail

Product Safety Recalls - Vape Cartridges

Americans for Safe Access

The issue of adulterants in cannabis vape products has once again resurfaced as the Pennsylvania Office of Medical Marijuana issued a notice to medical cannabis patients on February 4, 2022 advising them of a recall of over 500 different products containing substances not suitable for inhalation.

Vaping 236
article thumbnail

Intoxicating Hemp Swindle

Project CBD

Devitt expresses serious safety concerns. “Each ingredient has a well-documented safety profile at the included doses.” It’s about making a fast buck by selling synthetic cannabis substitutes under misleading branding while ignoring the health and safety of consumers,” says Devitt.

Hemp 214
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Philadelphia’s Restrictions on Pre-Employment Marijuana Tests Become Effective January 1, 2022

The Blunt Truth

Effective January 1, 2022, most Philadelphia employers will be prohibited from requiring prospective employees to undergo testing for the presence of marijuana as a condition of employment. Currently, only New York City and Nevada have similar drug testing restrictions, but we expect this trend to continue.

Marijuana 111
article thumbnail

Cannabis Law Journal February 2022 Issue Now Published

Cannabis Law Report

February 2022. The CDC recently issued guidance to businesses developing marijuana policies, balancing state legalization efforts and fleet safety. In this month’s issue. Michael Sassano: GMP Article No 9: Bringing New Products to GMP Facility. Luckily, … Read More. Per the CDC, … Read More.

Law 98
article thumbnail

The Scott of Pot At It Again. Cann Group aiming for over-the-counter CBD approval in late 2022

Cannabis Law Report

Phase I clinical trial of the Satipharm CBD capsules in which results demonstrated the safety and high performance of the oral capsule technology, including the superior delivery profile of cannabidiol (CBD) compound to trial subjects. Cann Group (ASX: CAN) aiming for over-the-counter CBD approval in late 2022.

article thumbnail

Michigan Cannabis Industry Must Be Prepared for Environmental, Health, and Safety Compliance Inspections from EGLE and MIOSHA

Dykema (Cannabis Law Blog)

As the Michigan cannabis industry continues to grow and mature, medical and adult-use licensees would be well served to take proactive steps to ensure compliance with Environmental, Health and Safety (EHS) regulations. Indeed, in November 2021, the MRA sent a voluntary survey to licensed processors across the State of Michigan.

article thumbnail

Nevada CCB – Public Health and Safety Bulletin 2022-02 – Mislabelling February 2, 2022 and March 28, 2022

Cannabis Law Report

Public Health and Safety Bulletin 2022-02. The Nevada Cannabis Compliance Board (CCB) is hereby issuing Public Health and Safety Bulletin 2022-02 on March 30, 2022 advising consumers and patients to avoid or take caution when consuming the cannabis products which are the subject of this notice.

Safety 52